Your browser doesn't support javascript.
loading
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer.
Pan, Yue; Fu, Yucheng; Zeng, Yue; Liu, Xiaohan; Peng, Yurong; Hu, Chunhong; Deng, Chao; Qiu, Zhenhua; Zou, Jian; Liu, Yuxuan; Wu, Fang.
Afiliação
  • Pan Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Fu Y; Hunan University of Chinese Medicine, Changsha, 410208, Hunan, People's Republic of China.
  • Zeng Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Liu X; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Peng Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Hu C; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Deng C; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Qiu Z; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Zou J; Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China.
  • Liu Y; Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China.
  • Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. wufang4461@csu.edu.cn.
Biomark Res ; 10(1): 9, 2022 Mar 07.
Article em En | MEDLINE | ID: mdl-35255999

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomark Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomark Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China